546.09
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha
Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView
Transamerica Large Core ESG's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
IDEXX Laboratories (IDXX) Institutional Ownership 2026 - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Analyst/Investor DaySlideshow (NASDAQ:IDXX) 2026-08-14 - Seeking Alpha
Handelsbanken Fonder AB Grows Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Singapore
IDEXX Laboratories Inc (IDXX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDXX|IDEXX Laboratories Inc|Price:569.852|Chg%:-0.728 - TradingKey
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment - marketscreener.com
IDEXX launches in-clinic cardiac test for cats and dogs - Investing.com
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test - Eagle-Tribune
Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating - marketscreener.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
NewEdge Advisors LLC Acquires 5,761 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc Stock Historical Valuations | HAM:IX1 - GuruFocus
IDEXX Laboratories Inc Stock Baskets - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock Price & 30 Year Financial Data - GuruFocus
IDEXX Laboratories (HAM:IX1) Other Operating Expense : €0 Mil (TTM As of Jun. 2026) - GuruFocus
IDEXX Laboratories (HAM:IX1) Marketable Securities : €0 Mil (As of Jun. 2026) - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Competitors 2026 - GuruFocus
IDEXX Laboratories Inc Stock Operating Data - GuruFocus
IDEXX Laboratories Inc (HAM:IX1) Stock News, Headlines & Updates - GuruFocus
Who's Buying or Selling IDEXX Laboratories Inc (HAM:IX1) Stock Today? - GuruFocus
IDEXX Labs posts 9% organic growth, raises EPS forecast, driven by global diagnostic expansion. - Pluang
IDEXX Laboratories: Worth The Premium (NASDAQ:IDXX) - Seeking Alpha
IDEXX Laboratories, Inc. $IDXX Shares Sold by Beacon Investment Advisory Services Inc. - MarketBeat
Assenagon Asset Management S.A. Boosts Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Aurora Investment Managers LLC. Makes New Investment in IDEXX Laboratories, Inc. $IDXX - MarketBeat
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Moomoo
Janus Henderson Group PLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Clinical Visits Keep Falling. IDEXX Laboratories’ Q2 Earnings Report Say That Doesn’t Matter. - TIKR.com
IDEXX Laboratories, Inc. $IDXX Shares Sold by Empowered Funds LLC - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat
IDEXX Labs Is Maintained at Neutral by UBS - Moomoo
IDEXX Labs Is Maintained at Neutral by Citigroup - Moomoo
Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792 - Moomoo
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo
Citi Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $670 - Moomoo
IDEXX Laboratories Inc (HAM:IX1) Stock Earnings Transcripts - GuruFocus
IDEXX Laboratories Inc (IDXX) Stock Up 3.6% and Still Undervalued -- GF Score: 96/100 - GuruFocus
IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights - GuruFocus
IDEXX Laboratories 2026: Revenue $1.22B, EPS $4.27— 10-Q Summary - TradingView
IDEXX Laboratories (NASDAQ: IDXX) lifts Q2 2026 profit and cash flow - Stock Titan
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Raised to $719, Implies 27% Upside - TradingView
Idexx Laboratories, Inc. Updates Earnings Guidance for 2026 - marketscreener.com
IDEXX Laboratories jumps 5% on strong results, raised guidance (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories Q2 Earnings Call Highlights - MarketBeat
Why Is IDEXX Laboratories Stock Gaining Tuesday? - Benzinga
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - Moomoo
Earnings call transcript: IDEXX tops Q2 2026 forecasts and lifts outlook - Investing.com
IDEXX Q2 earnings jump 18%, beating expectations - Mainebiz
IDEXX Laboratories' Q2 Earnings, Revenue Increase; 2026 Outlook Updated - marketscreener.com
IDEXX Laboratories Q2 2026 Earnings Call Transcript - Benzinga
IDEXX Laboratories Inc reports results for the quarter ended June 30Earnings Summary - TradingView
IDEXX LABORATORIES INC. R (IX1.DE) Q2 FY2026 earnings call transcript - Yahoo Finance
IDEXX Laboratories Shares Climb After Earnings Beat and Improved Full-Year Outlook - Yahoo Finance
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
IDEXX Labs stock rises nearly 4% on earnings beat and raised guidance - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):